What Martin Ventures does

Martin Ventures is a Nashville-based, healthcare-focused venture capital firm founded by Charlie Martin Jr. that invests its own permanent capital rather than managing a traditional limited-partner fund. The firm partners with healthcare entrepreneurs at all stages, including co-creating and incubating companies, and typically writes initial equity checks of $2–4 million into healthcare technology-enabled and SaaS-based businesses with $3M+ annual revenues, seeking valuation rooted in revenue or market multiples.

The portfolio spans value-based care enablement (Wellvana, Greater Good Health), home-based specialty care (Reimagine Care, StationMD, Cadence), specialty care management (Livara, Evergreen Nephrology), AI-driven clinical and revenue cycle operations (CodaMetrix, BEKhealth, ArcheHealth, Valar Labs), analytics (Trilliant Health, used by 70+ health systems), and behavioral health (Peregrine Health). CEO Devin Carty holds board or chairman roles across multiple portfolio companies, and founder Charlie Martin Jr. (ex-Chairman/CEO of Vanguard Health Systems, HealthTrust, and OrNda) remains actively involved as Chairman. The firm has funded 50+ companies, holds 30+ active investments, and reports 23 exits generating $14B+ aggregate enterprise value.

Economically, the firm earns returns through equity appreciation and exits rather than management fees; it operates with 1–10 employees at its 20 Burton Hills Blvd., Nashville headquarters, leveraging senior advisors (Phil Roe, Mark Montoney, Richard Francis) and investment committee members for deal sourcing, due diligence, and post-investment portfolio support including board service, customer introductions, recruiting, and back-office finance.

Name

Martin Ventures

Legal name

Martin Ventures

Website

http://www.martinventures.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

1–10 employees

Short description

Martin Ventures is a Nashville-based, healthcare-focused venture capital firm that invests its own permanent capital into and co-creates early-stage healthcare technology, SaaS, and value-based care companies, typically with $2–4 million initial checks, serving founders across digital health, AI, and care delivery.

Ownership category

akta.pro rank

Product category

Healthcare Venture Capital

NAICS

All Other Financial Investment Activities (52399), Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

akta.pro secondary industries

Healthcare & Life Sciences Growth Equity (FSANACAB), Early-Stage Venture Capital (Series A/B) (FSANAAAB)

Keywords

• Healthcare venture capital
• Private equity investment
• Healthcare startup funding
• Growth capital investing
• Healthcare company incubation

Headquarters

HQ city

Nashville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Investment Returns: Martin Ventures generates returns through equity investments in healthcare companies at various stages of development. As an investor using their own capital, returns are realized through company exits including IPOs and acquisitions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Martin Ventures is a healthcare-focused venture capital firm that invests its own capital in healthcare companies at all stages of development, including co-creating companies. It typically makes initial equity investments of $2-4 million in healthcare technology-enabled services, healthcare SaaS, digital health, value-based care, AI, and data science businesses that show year-over-year growth and $3M+ annual revenues. Beyond capital, the firm provides operational support, strategic guidance, mentoring, and access to its healthcare industry network to assist founders in building and scaling their companies.

Product overview

Martin Ventures is a healthcare-focused venture capital firm that invests its own capital in early-stage healthcare companies. The firm does not offer a unified product or platform; rather, it builds and invests in a portfolio of independent healthcare companies. The portfolio includes digital health, healthcare services, value-based care, AI, and data science companies such as Wellvana, Reimagine Care, Trilliant Health, Artera Health, BEKhealth, Cadence, CodaMetrix, Commure, Evergreen Nephrology, Greater Good Health, Harbor Health, Livara, OncoLens, Override Health, Peregrine Health, StationMD, Synapticure, Valar Labs, and Zus Health, among others.

Differentiator

Problem solved

Functional benefit

Products and services

• Healthcare Growth Equity Investment Direct equity capital investments of $2-4 million in healthcare technology-enabled, healthcare SaaS, digital health, value-based care, AI, and data science companies with $3M+ in annual revenues and year-over-year growth. The firm invests its own capital, partners at all stages, and is willing to co-create companies alongside founders.
• Operational and Strategic Advisory for Portfolio Companies Beyond capital, Martin Ventures provides ongoing operational support, strategic guidance, mentoring, board representation, customer introductions, recruiting support, and assistance with financial initiatives for its portfolio companies, leveraging 220+ collective years of healthcare operating experience.
• Back-Office Finance Services for Portfolio Companies Shared back-office finance services for closely held Martin Ventures portfolio companies, including cash management, accounting, financial statement preparation, external audit liaison, annual budgeting, payables/receivables support, and investor relations. Led by the SVP of Finance and Account Specialist teams.

Quantifiable outcome

• $14B+ enterprise value achieved across 50+ companies funded with 23 exits
• +1 more outcomes

Named customers13 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• LRVHealth: LRVHealth is a healthcare-focused venture capital firm investing in early- and growth-stage companies transforming the healthcare system. Direct peer given its similar healthcare-only thesis, growth-stage focus, and co-investment alongside Martin Ventures in portfolio companies such as Greater Good Health.
• Hatteras Venture Partners: Hatteras Venture Partners is a venture capital firm based in North Carolina investing in early-stage life sciences, healthcare IT, and tech-enabled services. Direct peer as a healthcare-vertical specialist that has led rounds in Martin Ventures portfolio companies (e.g., BEKHealth).
• Echo Health Ventures: Echo Health Ventures is a strategic venture capital partnership between Cambia Health Solutions and Blue Cross Blue Shield of North Carolina, investing in healthcare innovation. Direct peer as a healthcare-vertical specialist with strategic LP backing and overlapping focus on value-based care.
• Boston Millennia Partners: Boston Millennia Partners is a healthcare-focused growth equity and venture capital firm investing in commercial-stage healthcare companies. Direct peer given its sector-specialist model and co-investment alongside Martin Ventures in rounds such as BEKHealth's $4M financing.
• Optum Ventures: Optum Ventures is the dedicated corporate venture arm of Optum/UnitedHealth Group investing in healthcare technology and services. It is a direct peer to Martin Ventures as a healthcare-focused growth/Series A investor participating in rounds across Martin Ventures' portfolio (e.g., Greater Good Health).
• Flare Capital Partners: Flare Capital Partners is a Boston-based venture capital firm focused exclusively on early-stage healthcare technology companies. Comparable to Martin Ventures as a sector-specialist healthtech investor that has co-invested in Martin Ventures-backed companies such as Greater Good Health.
• Allumia Ventures: Allumia Ventures is a venture firm focused on early-stage healthcare technology companies, particularly in value-based care delivery. Direct peer given its healthcare-only thesis and its recent lead role in the Greater Good Health Series B alongside Martin Ventures.

Broad incumbents

• General Catalyst: General Catalyst is a major multi-stage venture capital firm with a substantial healthcare practice (Health Assurance) investing across the same themes as Martin Ventures (digital health, value-based care, AI in healthcare). Broad incumbent peer given its far larger fund size, but overlapping investment themes.
• Oak HC/FT: Oak HC/FT is a venture capital firm investing in early-to-growth-stage healthcare and financial services technology companies. Broad incumbent peer that operates in overlapping healthtech verticals (value-based care, digital health) but with a much larger AUM than Martin Ventures.
• Andreessen Horowitz (a16z Bio + Health): Andreessen Horowitz operates a major Bio + Health fund investing in healthcare and life sciences companies at the same stages as Martin Ventures. Broad incumbent peer given the overlap in digital health and value-based care thesis, though a16z has materially larger fund and team capacity.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/martinventures
• Facebookfacebook.com/4475475686018
• LinkedInlinkedin.com/company/342813

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments54 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Martin Ventures